CME and CFTC Clash Publicly Over Prediction Market Regulatory Authority
Nashnova编辑部
CME Group CEO Terry Duffy accused prediction markets of harboring manipulation at the CFTC's first Innovation Advisory Committee meeting; CFTC Chair Michael Selig dismissed the criticism as "fake news" — a rare public rupture that exposes deepening regulatory and commercial rivalry between legacy exchanges and upstart prediction platforms.
What "manipulation" is Duffy actually alleging?
Duffy cited two cases: a U.S. Army soldier charged with betting on the ouster of Venezuelan President Nicolás Maduro on offshore platform Polymarket (the soldier has pleaded not guilty), and a White House teleprompter operator under CFTC investigation for allegedly wagering on President Trump's speech content on Kalshi.
This means → Duffy's target is not prediction markets as a category. It is people using inside information to profit — if you know what the president will say and then bet on it, the logic is no different from insider trading.
Duffy's words: "There is manipulation going on in these contracts, and it is bad for all of us."
Why did the CFTC chair push back — and how heated did it get?
CFTC Chair Michael Selig called Duffy's criticism "fake news." Duffy shot back: "Fake news? All right, that's a cute statement."
In plain terms = the head of a regulatory agency told the CEO of its largest regulated entity, on the record in a public meeting, that he was spreading misinformation. In U.S. financial regulation, this is extraordinarily rare — the disagreement is no longer behind closed doors but openly fractured.
This reflects the CFTC's current posture: it does not see systemic manipulation on these platforms, or at least does not accept the severity Duffy described.
How did the upstart platforms respond?
Kalshi co-founder Luana Lopes Lara challenged Duffy directly: has CME never had manipulation problems of its own? Duffy replied that CME's compliance staff outnumber Kalshi's entire company. Lara fired back: "Maybe you should learn about efficiency."
Polymarket founder Shayne Coplan played the transparency card: trades run on a blockchain — a public ledger where every participant's history is visible to anyone — delivering what he called "unprecedented transparency."
Both platforms said they oppose insider trading and have proactively reported suspicious trades to regulators. This means → the upstarts' strategy is not to deny the problem but to argue their oversight and transparency exceed what legacy exchanges deliver.
How fierce is the commercial rivalry underneath?
CME's main competitor, Intercontinental Exchange (ICE), has invested over $1.6 billion in Polymarket. ICE CEO Jeff Sprecher said the same day he is considering joining Polymarket's latest funding round.
In plain terms = the traditional-exchange camp is already split. CME is attacking prediction markets; its old rival ICE is pouring money into them. Duffy's critique is not just a regulatory stance — it is an extension of commercial competition.
The conflict also extends to perpetual futures — derivatives with no expiry date and high leverage, popular in crypto markets. After the CFTC approved Kalshi to list crypto-linked perpetual futures in June, CME filed a lawsuit challenging that decision.
What should we watch next?
The regulatory boundary for prediction markets and the standard for defining manipulation are the key variables in the CFTC's next policy moves.
This means → if the CFTC ultimately adopts a loose definition of manipulation, Kalshi and Polymarket gain room to expand their product offerings. If Duffy's pressure works, these platforms face tighter compliance demands.
The deeper question: when a legacy exchange's own competitor is investing in the new platforms, can the line between regulatory argument and commercial interest still be drawn?
Content is for reference only, not financial advice.